Pachira Investments Inc. Bio Atla, Inc. Transaction History

Pachira Investments Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$29.44 - $43.74 $150,144 - $223,074	-5,100 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$38.07 - $56.17 $45,684 - $67,404	-1,200 Reduced 19.05%	5,100 $216,000
Q1 2021 Apr 22, 2021	BUY	$32.41 - $70.91 $204,182 - $446,733	6,300 New	6,300 $320,000

24.8M

140K

4.6K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $47.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Pachira Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Pachira Investments Inc. with notifications on news.